Dataset from A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Investigational Unadjuvanted RSV Maternal Vaccine Compared to Placebo When Administered to Healthy Non-pregnant Women.
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00007334
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate different dose levels of the investigational RSV
maternal vaccine (GSK3888550A) based on safety/reactogenicity and immune response data.
As this is the first time the investigational RSV maternal vaccine (GSK3888550A) is being
been used in humans, this study will be performed in healthy non-pregnant women 18-45 years
of age before testing in pregnant women.
创建时间：
2024-11-27
